iHuman Inc. (IH)
NYSE: IH · IEX Real-Time Price · USD
+0.060 (2.99%)
At close: May 22, 2024, 3:59 PM
+0.010 (0.48%)
After-hours: May 22, 2024, 7:00 PM EDT

iHuman Statistics

Total Valuation

iHuman has a market cap or net worth of $111.34 million. The enterprise value is -$55.96 million.

Market Cap 111.34M
Enterprise Value -55.96M

Important Dates

The next estimated earnings date is Thursday, June 20, 2024, before market open.

Earnings Date Jun 20, 2024
Ex-Dividend Date n/a

Share Statistics

iHuman has 53.53 million shares outstanding.

Shares Outstanding 53.53M
Owned by Insiders (%) n/a
Owned by Institutions (%) 8.74%
Float n/a

Valuation Ratios

The trailing PE ratio is 4.37 and the forward PE ratio is 58.14.

PE Ratio 4.37
Forward PE 58.14
PS Ratio 0.80
Forward PS n/a
PB Ratio 0.85
P/FCF Ratio 4.91
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.82, with a Debt / Equity ratio of 0.00.

Current Ratio 2.82
Quick Ratio 2.60
Debt / Equity 0.00
Debt / EBITDA 0.02
Debt / FCF 0.02
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 20.20% and return on invested capital (ROIC) is 14.85%.

Return on Equity (ROE) 20.20%
Return on Assets (ROA) 13.10%
Return on Capital (ROIC) 14.85%
Revenue Per Employee $183,400
Profits Per Employee $32,587
Employee Count 783
Asset Turnover 0.74
Inventory Turnover 16.66


In the past 12 months, iHuman has paid $3.05 million in taxes.

Income Tax 3.05M
Effective Tax Rate 10.69%

Stock Price Statistics

The stock price has decreased by -40.69% in the last 52 weeks. The beta is 0.35, so iHuman's price volatility has been lower than the market average.

Beta (1Y) 0.35
52-Week Price Change -40.69%
50-Day Moving Average 1.81
200-Day Moving Average 2.49
Relative Strength Index (RSI) 70.00
Average Volume (30 Days) 30,608

Short Selling Information

Short Interest 755
Short Previous Month 1,241
Short % of Shares Out 0.00%
Short % of Float n/a
Short Ratio (days to cover) 0.03

Income Statement

In the last 12 months, iHuman had revenue of $143.60 million and earned $25.52 million in profits. Earnings per share was $0.47.

Revenue 143.60M
Gross Profit 101.65M
Operating Income 22.53M
Pretax Income 28.55M
Net Income 25.52M
EBIT 28.55M
Earnings Per Share (EPS) $0.47
Full Income Statement

Balance Sheet

The company has $171.06 million in cash and $543,999 in debt, giving a net cash position of $170.52 million or $3.19 per share.

Cash & Cash Equivalents 171.06M
Total Debt 543,999
Net Cash 170.52M
Net Cash Per Share $3.19
Equity / Book Value 134.99M
Book Value Per Share 2.52
Working Capital 125.67M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $24.26 million and capital expenditures -$917,329, giving a free cash flow of $23.34 million.

Operating Cash Flow 24.26M
Capital Expenditures -917,329
Free Cash Flow 23.34M
FCF Per Share $0.44
Full Cash Flow Statement


Gross margin is 70.79%, with operating and profit margins of 15.69% and 17.77%.

Gross Margin 70.79%
Operating Margin 15.69%
Pretax Margin 19.88%
Profit Margin 17.77%
EBITDA Margin 21.03%
EBIT Margin 19.88%
FCF Margin 16.25%

Dividends & Yields

iHuman does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.32%
Shareholder Yield -1.32%
Earnings Yield 22.27%
FCF Yield 20.38%
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


iHuman has an Altman Z-Score of 2.76 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.76
Piotroski F-Score 7